Join Wyatt Hall (Director of Sales, Nanion Inc), and Ronald Knox (Senior Business Executive) to learn more about our newest impedance system, AtlaZ.

The AtlaZ enables label-free, continuous, real-time monitoring of cancer immune therapy effects in acute and chronic experiments that mirror in vivo treatment regimes and in high throughput (simultaneously using six 96-well plates). This approach gives researchers the necessary tools to gain deeper access to the kinetic and phenotypic cellular responses.

Would you like to learn more about AltaZ? Book a meeting with Wyatt and Ronald at AACR.

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.